NanoString Technologies Gains

NanoString Technologies Gains

NanoString Technologies gained in morning trading on Wednesday, a day after the provider of life science tools said Humana has issued a positive coverage decision for the Prosigna Breast Cancer Gene Signature Assay. Shares were trading up 2.2% to $18.44 after touching $18.60 earlier in the session. Humana and its more than 13 million members join other payors now covering Prosigna, collectively representing more than 175 million covered lives throughout […]

Read More ˃
AMD Provides Upbeat Q1 Revenue Guidance, Q4 Results Best Street View

AMD Provides Upbeat Q1 Revenue Guidance, Q4 Results Best Street View

AMD gained in extended trading on Tuesday after the semiconductor company forecast upbeat revenue for the current quarter while reporting a narrower-than-expected loss and higher-than-estimated revenue for the most recent quarter. For Q1, AMD expects revenue to increase 18% year-over-year, above the Capital IQ analyst expectation of 15.7% increase. Non-GAAP net loss narrowed to $0.01 in the December quarter, from $0.10 a year earlier. Analysts had predicted a loss of […]

Read More ˃
Zogenix Gets US Patent For ZX008 in Dravet Syndrome

Zogenix Gets US Patent For ZX008 in Dravet Syndrome

Zogenix shares were up pre-market Monday after the company said it was issued a U.S. patent for ZX008 for the treatment of Dravet Syndrome from the U.S. Patent & Trademark Office. “We are continuing to pursue multiple additional patent families related to ZX008 globally in order to further protect our lead product candidate,” CEO Stephen Farr said. “In addition, we are conducting certain pre-clinical and clinical development work in order […]

Read More ˃
Horizon Global Prices Offering of Equity

Horizon Global Prices Offering of Equity

Horizon Global was modestly higher in recent pre-market trade after pricing public offerings of 4 million common shares, or up to 4.6 million shares if underwriters exercise their option to buy additional shares in full, and $110 million in convertible senior notes due 2022. The common shares will be sold for $18.50 apiece. On the other hand, the notes will pay an interest of 2.75% per annum and are convertible […]

Read More ˃
Deluxe Q4 Results Meet Views

Deluxe Q4 Results Meet Views

Deluxe Corp. reported pre-market Thursday Q4 results which met analysts’ expectations compiled by Capital IQ. The company also reaffirmed its FY17 outlook in line with the Street view but issued slightly downside guidance for Q1. The provider of marketing solutions and printed forms said Q4 adjusted EPS was $1.35 per share, up from $1.26 per share a year earlier and matching forecasts compiled by Capital IQ. Revenues rose 3.6% year-over-year […]

Read More ˃